Drugmakers Dodge Another Bullet in Trump's Drug Pricing Report

A White House report on drug pricing is another sign pharmaceutical companies can rest easy: President Donald Trump won't act on past threats to take drastic measures to lower prices.

Continue reading at Bloomberg →
Recommended posts powered by Google